References
Frangieh AH, Ott I, Michel J, Shivaraju A, Joner M (2017) Standardized minimalistic transfemoral transcatheter aortic valve replacement (TAVR) using the SAPIEN 3 device: stepwise description, feasibility, and safety … structural. Taylor and Francis. https://doi.org/10.1080/24748706.2017.1358832
Gonska B, Seeger J, Keßler M, von Keil A, Rottbauer W, Wöhrle J (2017) Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve. Clin Res Cardiol 106:590–597
Schaefer A, Neumann N, Linder M, Schofer N, Schneeberger Y, Deuschl F et al (2018) Outcomes with a latest generation self-expandable, intra-annular, re-sheathable transcatheter heart valve system: analysis of patients with impaired left ventricular function and determinants for pacemaker implantation. Clin Res Cardiol. https://doi.org/10.1007/s00392-018-1263-x
Schaefer A, Linder M, Treede H, Deuschl F, Schofer N, Seiffert M et al (2016) Applicability of next generation balloon-expandable transcatheter heart valves in aortic annuli exceeding formally approved dimensions. Clin Res Cardiol 105:585–591
Ibebuogu UN, Giri S, Bolorunduro O, Tartara P, Kar S, Holmes D et al (2015) Review of reported causes of device embolization following trans-catheter aortic valve implantation. Am J Cardiol 115:1767–1772
Shivaraju A, Kodali S, Thilo C, Ott I, Schunkert H, von Scheidt W et al (2015) Overexpansion of the SAPIEN 3 transcatheter heart valve: a feasibility study. JACC Cardiovasc Interv 8:2041–2043
Ando T, Briasoulis A, Holmes AA, Taub CC, Takagi H, Afonso L (2016) Sapien 3 versus Sapien XT prosthetic valves in transcatheter aortic valve implantation: a meta-analysis. Int J Cardiol 220:472–478
Lauten A, Hamadanchi A, Doenst T, Figulla HR (2013) Late migration of balloon-expandable transcatheter aortic valve. Eur Heart J 34:2509
Pang PYK, Chiam PTL, Chua YL, Sin YK (2012) A survivor of late prosthesis migration and rotation following percutaneous transcatheter aortic valve implantation. Eur J Cardiothorac Surg 41:1195–1196
Clavel M-A, Dumont E, Pibarot P, Doyle D, De Larochellière R, Villeneuve J et al (2009) Severe valvular regurgitation and late prosthesis embolization after percutaneous aortic valve implantation. Ann Thorac Surg 87:618–621
Maeno Y, Abramowitz Y, Jilaihawi H, Israr S, Yoon S, Sharma RP et al (2017) Optimal sizing for SAPIEN 3 transcatheter aortic valve replacement in patients with or without left ventricular outflow tract calcification. EuroIntervention 12:e2177–e2185
Kim W-K, Blumenstein J, Liebetrau C, Rolf A, Gaede L, Van Linden A et al (2017) Comparison of outcomes using balloon-expandable versus self-expanding transcatheter prostheses according to the extent of aortic valve calcification. Clin Res Cardiol 106:995–1004
Bernhardt P, Rodewald C, Seeger J, Gonska B, Buckert D, Radermacher M et al (2016) Non-contrast-enhanced magnetic resonance angiography is equal to contrast-enhanced multislice computed tomography for correct aortic sizing before transcatheter aortic valve implantation. Clin Res Cardiol 105:273–278
Mohty D, Pradel S, Magne J, Fadel B, Boulogne C, Petitalot V et al (2017) Prevalence and prognostic impact of left-sided valve thickening in systemic light-chain amyloidosis. Clin Res Cardiol 106:331–340
Salzwedel A, Reibis R, Wegscheider K, Eichler S, Buhlert H, Kaminski S et al (2016) Cardiopulmonary exercise testing is predictive of return to work in cardiac patients after multicomponent rehabilitation. Clin Res Cardiol 105:257–267
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rheude, T., Pellegrini, C., Michel, J. et al. Late migration of Edwards SAPIEN 3 transcatheter heart valves: mechanisms and transcatheter treatment options for a rare phenomenon. Clin Res Cardiol 107, 1183–1186 (2018). https://doi.org/10.1007/s00392-018-1301-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-018-1301-8